A Simple and One-Pot Procedure for Synthesis of Highly Functionalized 617
1
8.79%. Found: C, 60.20; H, 4.87; N, 8.63%. H NMR (500.1 MHZ, CDCl3): δ = 1.21(3H, t,
3
3
3JHH = 7 HZ, CH3), 2.49 (3H, s, CH3), 4.13 (2H, q, JHH = 7 HZ, CH2), 3.66 (H, d, JHH
=
7.1HZ, CH), 4.48 (H, d, 3JHH = 7.1HZ, CH), 7.10 -7.38 (4H, m, aromatic), 12.74 (1 H, broad
s, NH). 13C NMR (125.7 MHZ, CDCl3): δ = 14.30 and 18.51 (2CH3), 40,99 and 41.83 (2CH),
60.31 (CH2), 104.62 (CN), 116.05 and 148.30 (C=C), 129.17, 130.04, 132.99, 137.50
(aromatic), 163.28 and 166.10 (2C=O).
Ethyl 5-cyano-2-methyl-6-oxo-4-(4-bromophenyl)-1,4,5,6-tetrahydropyridine 3-car-
boxylate (3A)
White powder, (61 %), m.p.175–177˚C, IR (KBr) (νmax/cm-1): 3414 (NH), 2210 (CN), 1697
(C=O). MS, m/z (%): 363 (M+., 8).Anal. Calcd for C16H15BrN2O3 : C, 52.91; H, 4.16; N,
1
7.71%. Found: C, 52.60; H, 4.25; N, 7.61%. H NMR (500.1 MHZ, CDCl3): δ = 1.22 (3H, t,
3
3
3JHH = 7 HZ, CH3), 2.46 (3H, s, CH3), 4.11 (2H, q, JHH = 7 HZ, CH2), 3.62 (H, d, JHH
=
7.1HZ, CH), 4.47 (H, d, 3JHH = 7.1HZ, CH), 7.12 -7.49 (4H, m, aromatic), 7.84(1 H, broad s,
NH). 13C NMR (125.7 MHZ, CDCl3): δ = 14.12 and 19.03 (2CH3), 40,99 and 41.07 (2CH),
60.97 (CH2), 107.38 (CN), 113.85 and 146.05 (C=C), 122.72, 129.35, 132.26, 134.93
(aromatic), 162.79 and 165.18 (2C=O).
Ethyl 5-cyano-2-methyl-6-oxo-4-(3-methoxyphenyl)-1,4,5,6-tetrahydropyridine 3-car-
boxylate (4A)
White powder, (57 %), m.p. 134–136˚C, IR (KBr) (νmax/cm-1): 3415 (NH), 2220 (CN), 1705
(C=O). MS, m/z (%): 314 (M+., 12).Anal. Calcd for C17H18N2O4 : C, 64.96; H, 5.77; N,
1
8.91%. Found: C, 64.88; H, 5.70; N, 8.95 %. H NMR (500.1 MHZ, CDCl3): δ = 1.24 (3H, t,
3
3JHH = 7 HZ, CH3), 2.44 (3H, s, CH3), 3.80 (3H, s, OCH3), 4.16 (2H, q, JHH = 7 HZ, CH2),
3
3
4.10 (H, d, JHH = 7.1HZ, CH), 4.48 (H, d, JHH = 7.1HZ, CH), 6.79-7.29 (4H, m, aromatic),
7.82 (1 H, broad s, NH). 13C NMR (125.7 MHZ, CDCl3): δ = 14.11 and 18.87 (2CH3), 39.82
and 42.91 (2CH), 55.23 (OCH3), 60.82 (CH2), 107.61 (CN), 113.39 and 146.02 (C=C),
113.08, 114.13, 120.03, 130.07, 137.51 159.87 (aromatic), 163.20 and 165.02 (2C=O).
Ethyl 5-cyano-2-methyl-6-oxo-4-(2-nitrophenyl)-1,4,5,6-tetrahydropyridine 3-car-
boxylate (5A)
White powder, (54 %), m.p. 166–168 ˚C, IR (KBr) (νmax/cm-1): 3400 (NH), 2250 (CN), 1704
1
3
(C=O), 1346 and 1523 (NO2). H NMR (500.1 MHZ, CDCl3): δ = 1.10 (3H, t, JHH = 7 HZ,
3
3
CH3), 2.57 (3H, s, CH3), 4.04 (2H, q, JHH = 7 HZ, CH2), 3.97 (H, d, JHH = 7.1HZ, CH),
4.29 (H, d, JHH = 7.1HZ, CH), 7.20 -7.98 (4H, m, aromatic), 8.03(1 H, broad s, NH). 13C
3
NMR (125.7 MHZ, CDCl3): δ = 13.75 and 18.91(2CH3), 39.93 and 41.95 (2CH), 60.97
(CH2), 106.66 (CN), 114.94 and 147.46 (C=C), 125.58, 128.30, 129.48, 132.90, 134.01,
148.89 (aromatic), 163.08 and 165.22 (2C=O).
Ethyl 5-cyano-2-methyl-6-oxo-4-(3-nitrophenyl)-1,4,5,6-tetrahydropyridine 3-car-
boxylate (6A)
White powder, (68 %), m.p. 190–192 ˚C, IR (KBr) (νmax/cm-1): 3410 (NH), 2230 (CN), 1707
3
(C=O), 1319 and 1525 (NO2).1H NMR (500.1 MHZ, CDCl3): δ = 1.09 (3H, t, JHH = 7 HZ,
3
3
CH3), 2.35 (3H, s, CH3), 4.01 (2H, q, JHH = 7 HZ, CH2), 4.31 (H, d, JHH = 7.1HZ, CH),
4.47 (H, d, JHH = 7.1HZ, CH), 7.46 -8.09 (4H, m, aromatic), 10.54 (1 H, broad s, NH). 13C
3
NMR (125.7 MHZ, CDCl3): δ = 14.04 and 18.87 (2CH3), 44.81 and 45.94 (2CH), 65.28
(CH2), 110.05 (CN), 112.13 and 153.14 (C=C), 120.25, 127.97, 134.80, 139.28, 144.37,
153.49 (aromatic), 163.97 and 166.92 (2C=O).
Ethyl 5-cyano-2-methyl-6-oxo-4-(4-nitrophenyl)-1,4,5,6-tetrahydropyridine 3-car-
boxylate (7A)